Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending July 1
McDonald’s, Dollar Tree, GoFundMe, Stride, Otis, Intrusion, Monogram Health, Mass Luminosity
By
Lauren Muskett
| July 1, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Bayer
M&A
Elanco to Buy Bayer Animal Health Unit for $7.6B
The deal would make Elanco the second biggest animal health business in the world.
By
Lauren Muskett
| August 20, 2019
Read More
M&A
Bayer to Shed Assets, Cut Jobs Amid Share Pressure
It's a broad restructuring of the German conglomerate, which plans to sell its sun-care and foot care businesses and exit its animal health division.
By
William Sprouse
| November 29, 2018
Read More
Risk & Compliance
Monsanto Cancer Verdict Rattles Bayer Shares
Analysts warn Bayer could face a "litigious headache" after the $289 million jury award in a product liability case over Monsanto's Roundup pesticide.
By
Matthew Heller
| August 14, 2018
Read More
Financial Performance
Monsanto Misses Estimates on Corn Slowdown
"Despite tough farm economics, we delivered a solid second quarter and are staying disciplined on near-term execution of the business," CEO Hugh Grant says.
By
Matthew Heller
| April 5, 2018
Read More
Strategy
BASF to Buy Bayer Seed Businesses for $6.9B
The deal may help clear the way for European authorities to approve Bayer's acquisition of Monsanto early next year.
By
Matthew Heller
| October 13, 2017
Read More
Sustainability
Free from Bayer, Covestro Finally Can Build for the Future
The spun-off materials science company had to build out most functions from scratch but has seen surprising early business results.
By
David McCann
| May 4, 2017
Read More
Strategy
Bayer Clinches Monsanto Takeover for $66B
The deal continues the wave of consolidation in agribusiness, pairing Bayer's strength in crop chemicals with Monsanto's portfolio of seed products.
By
Matthew Heller
| September 14, 2016
Read More
Risk
The Year of Dealing Dangerously
Antitrust actions, buyer cautiousness, and longer due diligence phases have all contributed to a slowdown in mergers and acquisitions.
By
Vincent Ryan
| July 14, 2016
Read More
Strategy
Bayer Discloses $62B Offer for Monsanto
The deal would create the world's largest agricultural supplier but Bayer shareholders fear it will be detrimental to its pharmaceutical business
By
Katie Kuehner-Hebert
| May 23, 2016
Read More
Technology
Health Care: Things are Looking App
Mobile health apps are becoming more capable and potentially rather useful.
By
Economist Staff
| March 14, 2016
Read More